Silicon heterojunction solar cell with a certified 23.1 % energy conversion efficiency

After further optimization of the baseline process for industrial silicon heterojunction (SHJ) solar cells, the accredited metrology lab ISFH CalTeC now certified an efficiency of 23.1 % for a 4 cm² solar cell. This performance is among the best in the world and demonstrates the leading role of HZB in this technology in Germany and Europe.

Within the institute PVcomB at HZB we develop SHJ cells with the focus on improving industrial applicable materials and processes in collaboration with industry partners (e.g. Meyer Burger, Von Ardenne, Singulus). Moreover, new types of solar cells with the potential to surpass the efficiency limit of silicon-based cells, such as perovskite/SHJ tandem junctions, are developed at HZB, partially in collaboration with industry (Oxford PV). Results will be presented this year at the international PV conferences WCPEC (June 10-15, Hawaii) and EUPVSEC (Sep 24-28, Brussels).

Background

Silicon heterojunction (SHJ) solar cells are made of crystalline silicon wafers using passivated contacts for both polarities based on i/n and i/p stacks of thin-film silicon alloys, such as amorphous silicon, nano-crystalline silicon or silicon oxide. Due to a high silicon wafer quality and the excellent surface passivation SHJ solar cells reach very high conversion efficiencies with highest open circuit voltages >740 mV and low temperature coefficient <0.3 %/K. With this type of two-side contacted cell Kaneka Corp. (Japan) holds the world record with a 25.1 % conversion efficiency. Recently, they attracted attention with 26.7 % for an all-rear-side contacted (IBC) SHJ cell, which is currently the world record for a silicon-based solar cell. For commercial production, the lean process sequence consisting of only four major process steps, all below <200°C processing temperature, facilitate cost-effective cell production.

(bs)

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.